Causes

Chlamydia is caused by the obligate intracellular bacterium Chlamydia trachomatis.

Clinical presentation

Chlamydia is usually asymptomatic.

People with a penis

Symptoms - urethral discharge, dysuria and/or anorectal symptoms (Refer to Proctitis treatment guidelines).
Complications - epididymo-orchitis (for people with testes). Refer to Epididymo-orchitis treatment guidelines.
 

People with a vagina

  • Symptoms - vaginal discharge, dysuria, post coital bleeding and/or anorectal symptoms (Refer to Proctitis treatment guidelines).
  • Complications:
    • Pelvic inflammatory disease (PID, in people with a cervix, uterus, fallopian tubes or ovaries) - chronic pelvic pain, ectopic pregnancy and infertility. Refer to PID treatment guidelines.
    • Pregnant person to child transmission - neonatal conjunctivitis and pneumonitis.

Diagnosis

People with a penis

Test Site/Specimen Comments
NAAT FPU If gay, bisexual or other men who have sex with men (GBMSM), also collect anal and pharyngeal swabs even if asymptomatic at these sites.
NAAT Anorectal swab

If GBMSM, and patient declines anal examination or has no anorectal symptoms, instruct in self-collection.

Self-collection is as sensitive as swabs taken by a clinician and may be preferred by some people.

NAAT Pharyngeal swab Collect if GBMSM. Self-collection is as sensitive as swabs taken by a clinician and may be preferred by some people.

People with a vagina

Test Site/Specimen Comments
NAAT Endocervical swab Best test if examined.
NAAT Self-collected vaginal swab

As sensitive as clinician taken swabs, and are acceptable to many people.

NAAT FPU If endocervical swab/self-collected vaginal swab cannot be taken, for example after a hysterectomy, or in clients with a neovagina. Not as sensitive as self-collected vaginal swab.
NAAT Anorectal swab

If patient has had anal sex or has anorectal symptoms.

If patient declines anal examination, refer patient for testing at a sexual health centre.

If a chlamydia result is equivocal or inhibitors are present the test should be repeated. If the initial test was a urine sample, the repeat test should be performed by taking a urethral swab as the inhibitors may persist in the urine.

Management

Index patient

Chlamydia is notifiable to the Victorian Health Department by laboratories.

Condition First-line treatment Alternative
Uncomplicated genital or pharyngeal infection

Doxycycline 100mg per oral, twice daily for 7 days.

Azithromycin 1g per oral, stat.

Consider for patients likely to be nonadherent to doxycycline.

Anorectal infection

Doxycycline 100mg per oral, twice daily for 7 days.

If symptomatic, consider LGV

Refer to LGV treatment guidelines

Refer to Proctitis treatment guidelines

Azithromycin 1g per oral, stat, and repeat in 12-24 hours.

Doxycycline is superior to azithromycin for anorectal chlamydia.  Perform a test of cure if using azithromycin in those with anorectal infection (see below).

Pelvic inflammatory disease

Consider PID when chlamydia is diagnosed in a patient with female reproductive organs.

Refer to Pelvic inflammatory disease treatment guidelines

 
Epididymo-orchitis Refer to Epididymo-orchitis treatment guidelines  
Pregnant women

Azithromycin 1g PO, stat

Doxycycline is contraindicated.

If azithromycin is contraindicated:

Amoxycillin 500mg PO, 3 times a day for 7 days

OR

Erythromycin ethylsuccinate (EES) 800mg PO, 4 times a day for 7 days

OR

Erythromycin ethylsuccinate (EES) 400mg PO, 4 times a day for 14 days

Notification

Chlamydia is a notifiable disease in all Australian states/territories. The diagnosing clinician and/or the pathology laboratory is responsible for notification, depending on the jurisdiction. Pathology laboratories are responsible for notification in Victoria.

Partner management and patient delivered partner therapy

See Partner management and patient delivered partner therapy.
 

Follow up

CT Treatment chart

  • A test for re-infection is recommended 3 months post-treatment to detect re-infection as re-infection is most common within three months of the initial infection.
  • A test of cure is not routinely recommended except in:
    • Pregnant people, and
    • Anorectal infection treated with Azithromycin.
  • If a test of cure is performed, it should not be done within 4 weeks post-treatment to prevent false positive due to persistent chlamydia DNA.

Disclaimer

We recognise that gender identity is fluid. In our treatment guidelines, the words and language we use to describe genitals and gender are based on the sex assigned at birth.

The content of these treatment guidelines is for information purposes only. The treatment guidelines are generic in character and should be applied to individuals only as deemed appropriate by the treating practitioner on a case by case basis. Alfred Health, through MSHC, does not accept liability to any person for the information or advice (or the use of such information or advice) which is provided through these treatment guidelines. 

The information contained within these treatment guidelines is provided on the basis that all persons accessing the treatment guidelines undertake responsibility for assessing the relevance and accuracy of the content and its suitability for a particular patient. Responsible use of these guidelines requires that the prescriber is familiar with contraindications and precautions relevant to the various pharmaceutical agents recommended herein.